Leszek Lisowski

Consultant / Advisor at 4BIO Ventures Management Ltd.

Consumer Services

Health Technology

Finance

Profile

Leszek Lisowski founded LogicBio Therapeutics, Inc. in 2014, where he worked as President & Chief Executive Officer.
Dr. Lisowski also currently works at 4BIO Ventures Management Ltd., as Advisor.
Dr. Lisowski also formerly worked at The Salk Institute for Biological Studies, as Director from 2013 to 2015.
Dr. Lisowski received his doctorate degree in 2008 from Cornell University, undergraduate degree in 2001 from the University of Bridgeport, and Masters Business Admin degree in 2015 from the University of California San Diego.

Leszek Lisowski active positions

Companies	Position	Start
4BIO Ventures Management Ltd. 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom.	Consultant / Advisor	-

All active positions of Leszek Lisowski

Former positions of Leszek Lisowski

Companies	Position	End
The Salk Institute for Biological Studies	Director/Board Member	30/09/2015
LOGICBIO THERAPEUTICS, INC.	Chief Executive Officer	-

See the detail of Leszek Lisowski's experience

Training of Leszek Lisowski

Cornell University	Doctorate Degree
University of California San Diego	Masters Business Admin
University of Bridgeport	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Leszek Lisowski's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
LogicBio Therapeutics, Inc. LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA.	Health Technology
4BIO Ventures Management Ltd. 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom.	Finance

Private companies